ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC

Determine the 10-year risk of hard ASCVD, i.e., myocardial infarction, stroke, or death due to coronary heart disease or stroke.

“`html
Cardiovascular Risk

ASCVD Risk Calculator

Estimates the 10-year risk of a first hard atherosclerotic cardiovascular disease event, including myocardial infarction, coronary heart disease death, or stroke.

Years
Based on the original pooled cohort equations.
mg/dL
mg/dL
mmHg
Clinical note: This tool is intended for adults aged 40–79 years without known ASCVD. Use the result alongside clinical judgement and a full cardiovascular risk assessment.

Risk Categories

  • Low risk< 5%
  • Borderline risk5%–7.4%
  • Intermediate risk7.5%–19.9%
  • High risk≥ 20%

Important

This calculator is for educational and clinical support purposes only. It does not replace professional medical advice, diagnosis, treatment decisions, or shared decision-making with a clinician.

“`

How to interpret the result (quick guide)

  • Low risk (<5%) – Emphasize lifestyle optimization.
  • Borderline (5–7.4%) – Consider risk-enhancing factors and shared decision-making.
  • Intermediate (7.5–19.9%) – Discuss starting statin therapy and tightening BP control per ACC/AHA guidance.
  • High (≥20%) – Statin therapy is generally recommended; intensify risk-factor management.

References

  1. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk—derivation and validation of the Pooled Cohort Equations (PCE). AHA Journals
  2. ACC/AHA ASCVD Risk Estimator (web app)—official tool and risk category cut points. tools.acc.org+1
  3. EBMcalc implementation notes—explicit PCE coefficients (S10, MeanTerms, and all term multipliers) used above. ebmcalc.com
  4. ClinCalc PCE overview—scope, inputs, and practical notes on use. clincalc.com

Safety note: This calculator supports clinical conversations but doesn’t replace clinician judgment, individualized risk-benefit discussions, or local guideline updates (e.g., CAC scoring for borderline/intermediate risk).

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top